ATE274600T1 - Verfahren zur bestimmung der blutgerinnung in plasma - Google Patents
Verfahren zur bestimmung der blutgerinnung in plasmaInfo
- Publication number
- ATE274600T1 ATE274600T1 AT99928416T AT99928416T ATE274600T1 AT E274600 T1 ATE274600 T1 AT E274600T1 AT 99928416 T AT99928416 T AT 99928416T AT 99928416 T AT99928416 T AT 99928416T AT E274600 T1 ATE274600 T1 AT E274600T1
- Authority
- AT
- Austria
- Prior art keywords
- blood
- clotting
- cti
- plasma
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Diabetes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8848898P | 1998-06-08 | 1998-06-08 | |
PCT/US1999/012631 WO1999064622A1 (en) | 1998-06-08 | 1999-06-08 | Inhibition of coagulation in blood and blood products |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE274600T1 true ATE274600T1 (de) | 2004-09-15 |
Family
ID=22211667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99928416T ATE274600T1 (de) | 1998-06-08 | 1999-06-08 | Verfahren zur bestimmung der blutgerinnung in plasma |
Country Status (8)
Country | Link |
---|---|
US (2) | US6403381B1 (de) |
EP (1) | EP1084270B1 (de) |
JP (1) | JP2002517739A (de) |
AT (1) | ATE274600T1 (de) |
AU (1) | AU757459B2 (de) |
CA (1) | CA2333890A1 (de) |
DE (1) | DE69919702T2 (de) |
WO (1) | WO1999064622A1 (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1084270B1 (de) * | 1998-06-08 | 2004-08-25 | The University Of Vermont And State Agricultural College | Verfahren zur Bestimmung der Blutgerinnung in Plasma |
AU6369700A (en) * | 1999-07-23 | 2001-02-13 | Coagulation Diagnostics, Incorporated | Method for measuring coagulant factor activity in whole blood |
US20020116222A1 (en) * | 2000-10-22 | 2002-08-22 | Standing Stone, Inc. | Method and system for administering anticoagulation therapy |
US7411006B2 (en) * | 2000-10-23 | 2008-08-12 | Shanbrom Technologies, Llc | Enhanced production of blood clotting factors and fibrin fabric |
US7297716B2 (en) * | 2000-10-23 | 2007-11-20 | Shanbrom Technologies, Llc | Enhanced production of blood components, blood cells and plasma without freezing |
US8389687B2 (en) * | 2000-10-23 | 2013-03-05 | Shanbrom Technologies, Llc | Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors |
US6645768B1 (en) * | 2000-10-27 | 2003-11-11 | Biomerieux, Inc. | Reagent and kit for determining global coagulability and hemostatic potential |
US6743596B1 (en) * | 2000-10-27 | 2004-06-01 | Biomerieux, Inc. | Method of determining global coagulability hemostatic potential |
US7358337B2 (en) * | 2002-08-16 | 2008-04-15 | International Technidyne Corporation | Assay for low molecular weight heparin |
WO2005017486A2 (en) * | 2003-06-09 | 2005-02-24 | Mann Kenneth G | A global test of the hemostatic system |
CA2566411A1 (en) * | 2004-05-11 | 2005-11-24 | Heptest Laboratories, Inc. | Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities |
RU2514878C2 (ru) * | 2004-12-23 | 2014-05-10 | Ксл Бехринг Гмбх | Предотвращение образования и/или стабилизации тромбов |
US8070678B2 (en) * | 2005-10-05 | 2011-12-06 | Gurbel Paul A | Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength |
US8197420B2 (en) | 2006-12-18 | 2012-06-12 | Magnolia Medical Technologies, Inc. | Systems and methods for parenterally procuring bodily-fluid samples with reduced contamination |
WO2009046274A1 (en) * | 2007-10-03 | 2009-04-09 | The University Of Vermont And State Agriculture College | Methods of detection of factor xia and tissue factor |
CA2740785C (en) * | 2008-10-15 | 2017-06-20 | Isis Pharmaceuticals, Inc. | Modulation of factor 11 expression |
US8448499B2 (en) | 2008-12-23 | 2013-05-28 | C A Casyso Ag | Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method |
WO2012159021A2 (en) * | 2011-05-19 | 2012-11-22 | Hemosonics, Llc | Portable hemostasis analyzer |
CN102262161B (zh) * | 2011-08-16 | 2013-09-11 | 天津市百利康泰生物技术有限公司 | 水蛭素在特定条件下失活后检测凝血四项方面的应用 |
JP6491880B2 (ja) * | 2011-08-23 | 2019-03-27 | シナプス・ビー.ブイ.Synapse B.V. | 異物表面との接触による血液凝固系の活性化の熱安定性阻害剤 |
US8864684B2 (en) | 2011-10-13 | 2014-10-21 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
US8535241B2 (en) | 2011-10-13 | 2013-09-17 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
US20130149386A1 (en) * | 2011-12-07 | 2013-06-13 | Region Nordjylland | Cd36 as biomarker for steatosis |
US9022950B2 (en) | 2012-05-30 | 2015-05-05 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
US9060724B2 (en) | 2012-05-30 | 2015-06-23 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
US9204864B2 (en) | 2012-08-01 | 2015-12-08 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
EP3318295B1 (de) | 2012-10-11 | 2021-04-14 | Magnolia Medical Technologies, Inc. | System zur abgabe eines fluids an einen patienten mit reduzierter kontamination |
CA3136331C (en) | 2012-11-30 | 2024-05-21 | Magnolia Medical Technologies, Inc. | Syringe based fluid diversion mechanism for bodily-fluid sampling |
US10772548B2 (en) | 2012-12-04 | 2020-09-15 | Magnolia Medical Technologies, Inc. | Sterile bodily-fluid collection device and methods |
IL295772B2 (en) | 2012-12-04 | 2023-11-01 | Magnolia Medical Technologies Inc | Sterile device and methods for collecting body fluids |
CA2899594A1 (en) * | 2013-02-01 | 2014-08-07 | Keith A. Moskowitz | Blood collection devices containing contact pathway inhibition additives |
EP3461405A1 (de) | 2013-03-12 | 2019-04-03 | Magnolia Medical Technologies, Inc. | Verfahren und vorrichtung zum selektiven verschliessen des lumens einer nadel |
US20150050677A1 (en) * | 2013-08-16 | 2015-02-19 | University Of Massachusetts Medical School | Methods and systems for measuring whole blood platelet reactivity |
RU2556116C2 (ru) | 2013-11-28 | 2015-07-10 | Общество с ограниченной ответственностью "Гематологическая Корпорация" (ООО "ГемаКор") | Высокоселективный ингибитор контактной активации на основе инфестина 4 |
EP4218708A3 (de) | 2014-03-03 | 2023-08-16 | Magnolia Medical Technologies, Inc. | Vorrichtung und verfahren zur desinfektion eines probenbehälters |
US10539579B2 (en) | 2014-09-29 | 2020-01-21 | C A Casyso Gmbh | Blood testing system and method |
EP4059426B1 (de) | 2015-06-12 | 2023-12-13 | Magnolia Medical Technologies, Inc. | Vorrichtung zum spritzenbasierten fluidtransfer zur probenahme von körperflüssigkeiten |
EP4249119A3 (de) | 2015-09-03 | 2023-11-29 | Magnolia Medical Technologies, Inc. | System zum aufrechterhalten der sterilität eines probenbehälters |
JP6864008B2 (ja) * | 2016-04-25 | 2021-04-21 | インストゥルメンテーション ラボラトリー カンパニー | 抗リン脂質抗体症候群に関連するループス抗凝固因子(la)を特定するための方法およびキット |
AU2018334138B2 (en) | 2017-09-12 | 2024-05-23 | Magnolia Medical Technologies, Inc. | Fluid control devices and methods of using the same |
JP7229267B2 (ja) | 2017-12-07 | 2023-02-27 | マグノリア メディカル テクノロジーズ,インコーポレイテッド | 流体制御デバイスおよびその使用方法 |
WO2019217527A1 (en) | 2018-05-09 | 2019-11-14 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing fxi expression |
AU2020218544A1 (en) | 2019-02-08 | 2021-09-16 | Magnolia Medical Technologies, Inc. | Devices and methods for bodily fluid collection and distribution |
EP4265186A3 (de) | 2019-03-11 | 2024-01-17 | Magnolia Medical Technologies, Inc. | Fluidsteuerungsvorrichtungen |
CN113325185B (zh) * | 2021-07-09 | 2024-04-19 | 重庆鼎润医疗器械有限责任公司 | 多水平质控品及其制备方法和在血栓弹力图检测上的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4882272A (en) * | 1986-10-01 | 1989-11-21 | Temple University - Of The Commonwealth System Of Higher Education | High molecular weight kininogen assay |
US5318910A (en) | 1988-11-10 | 1994-06-07 | International Technidyne Corp. | Standard whole blood composition for determining the potency of blood clotting inhibitory substances |
US5472850A (en) | 1991-04-10 | 1995-12-05 | Oklahoma Medical Research Foundation | Quantitative clotting assay for activated factor VII |
US5314826A (en) | 1991-08-23 | 1994-05-24 | Medtronic Hemotec, Inc. | Platelet activation and function evaluation technique |
US5705395A (en) | 1994-11-14 | 1998-01-06 | The Scripps Research Institute | Method for diagnosis of thrombotic disorders |
EP1084270B1 (de) * | 1998-06-08 | 2004-08-25 | The University Of Vermont And State Agricultural College | Verfahren zur Bestimmung der Blutgerinnung in Plasma |
-
1999
- 1999-06-08 EP EP99928416A patent/EP1084270B1/de not_active Expired - Lifetime
- 1999-06-08 AT AT99928416T patent/ATE274600T1/de not_active IP Right Cessation
- 1999-06-08 AU AU45486/99A patent/AU757459B2/en not_active Expired
- 1999-06-08 CA CA002333890A patent/CA2333890A1/en not_active Abandoned
- 1999-06-08 DE DE69919702T patent/DE69919702T2/de not_active Expired - Lifetime
- 1999-06-08 WO PCT/US1999/012631 patent/WO1999064622A1/en active IP Right Grant
- 1999-06-08 US US09/327,806 patent/US6403381B1/en not_active Expired - Lifetime
- 1999-06-08 JP JP2000553612A patent/JP2002517739A/ja active Pending
-
2001
- 2001-04-27 US US09/844,209 patent/US6566140B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6566140B2 (en) | 2003-05-20 |
EP1084270A1 (de) | 2001-03-21 |
JP2002517739A (ja) | 2002-06-18 |
WO1999064622A1 (en) | 1999-12-16 |
DE69919702T2 (de) | 2005-09-15 |
US6403381B1 (en) | 2002-06-11 |
DE69919702D1 (de) | 2004-09-30 |
AU757459B2 (en) | 2003-02-20 |
AU4548699A (en) | 1999-12-30 |
EP1084270A4 (de) | 2001-12-05 |
US20020042144A1 (en) | 2002-04-11 |
EP1084270B1 (de) | 2004-08-25 |
CA2333890A1 (en) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE274600T1 (de) | Verfahren zur bestimmung der blutgerinnung in plasma | |
WO2007026251A8 (en) | Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma | |
DE69709727D1 (de) | Parazinon thrombin inhibitoren | |
DE59908887D1 (de) | Verfahren zur ein- bzw. abschaltung von verbrauchern | |
WO2004037159A3 (en) | Compounds, compositions and methods for modulating fat metabolism | |
ATE349936T1 (de) | Tablett zum tragen von gegenständen, insbesondere für kühlschränke | |
DK1766592T4 (da) | Holder til flere genstande og med en indretning til advarsel mod tyveri | |
ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
TR199902545T2 (xx) | Kalp damar hastal�klar�n�n �nlenmesinde siklooksijenaz-2 inhibit�rlerini kullanma y�ntemi | |
ATE446776T1 (de) | Zusammensetzung zur gefässbeschichtung | |
WO2003020880A3 (en) | Method of identifying inhibitors of lck | |
ATE287402T1 (de) | Nanomolare, non-peptidische inhibitoren von cathepsin d | |
WO2006023603A3 (en) | Pde5 inhibitor compositions and methods for treating cardiac indications | |
WO2002032435A3 (en) | A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade | |
HUP0001550A2 (hu) | Fagyasztott élelmiszertermék | |
IT1290209B1 (it) | Ripiano in particolare per vano frigorifero | |
HRP20090407T1 (en) | Hair growth inhibition | |
WO2001072778A3 (en) | Method of identifying inhibitors of tie-2 | |
DK1216307T4 (da) | Fremgangsmåde til detektion af rester af antimikrobielle midler | |
DE69941292D1 (de) | Schlange, pseudonaja textilis textilis | |
WO2001016300A3 (en) | Method of identifying inhibitors of cdc25 | |
AU2002364817A8 (en) | Method for guaranteeing at least one characteristic of a fluid used for producing food products | |
DE69903509D1 (de) | Ablage für senkrechten Gefrierschrank | |
DE50111812D1 (de) | Verfahren zur konservierung von nahrungsmitteln | |
WO2005054437A3 (en) | Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitor of type i and/or type ii phosphodiesterases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |